NCT03200587 2024-07-03Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)University of UtahPhase 1 Completed12 enrolled
NCT05012865 2023-12-06Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)PfizerCompleted48 enrolled 36 charts